Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Nishio · SciRah

Researcher profile · Semantic Scholar

S. Nishio

Share profile

S. Nishio — researcher profile on SciRah

h-index: 22
Works: 130
Citations: 1,993

Most-cited papers

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
S. Westin, K. Moore, H. Chon, Jung-Yun Lee +26 more
2023Journal of Clinical Oncology331 citations Open access
Semantic Scholar
Analysis of gastric-type mucinous carcinoma of the uterine cervix - An aggressive tumor with a poor prognosis: A multi-institutional study.
S. Nishio, Y. Mikami, H. Tokunaga, N. Yaegashi +15 more
2019Gynecologic Oncology142 citations Open access
Semantic Scholar
Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species.
T. Mizuno, N. Suzuki, H. Makino, T. Furui +12 more
2015Gynecologic Oncology101 citations Open access
Semantic Scholar
Applicability of the concept of "platinum sensitivity" to recurrent endometrial cancer: the SGSG-012/GOTIC-004/Intergroup study.
S. Nagao, S. Nishio, H. Michimae, H. Tanabe +6 more
2013Gynecologic Oncology77 citations
Semantic Scholar
Diagnosis, clinicopathologic features, treatment, and prognosis of small cell carcinoma of the uterine cervix; Kansai Clinical Oncology Group/Intergroup study in Japan.
Kuji Shiho, Y. Hirashima, H. Nakayama, S. Nishio +6 more
2013Gynecologic Oncology70 citations
Semantic Scholar
Clinicopathologic features of brain metastases from gynecologic malignancies: a retrospective study of 139 cases (KCOG-G1001s trial).
K. Nasu, T. Satoh, S. Nishio, Y. Nagai +6 more
2013Gynecologic Oncology51 citations
Semantic Scholar
Pembrolizumab monotherapy in Japanese patients with advanced ovarian cancer: Subgroup analysis from the KEYNOTE‐100
S. Nishio, Koji Matsumoto, K. Takehara, N. Kawamura +13 more
2020Cancer Science39 citations Open access
Semantic Scholar
Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE‐826
S. Nishio, K. Yonemori, T. Usami, S. Minobe +15 more
2022Cancer Science35 citations Open access
Semantic Scholar
Postoperative chemotherapy for node-positive cervical cancer: Results of a multicenter phase II trial (JGOG1067).
M. Matoda, N. Takeshima, H. Michimae, T. Iwata +14 more
2018Gynecologic Oncology34 citations
Semantic Scholar
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer
S. Pignata, M. Bookman, J. Sehouli, A. Miller +21 more
2023Gynecologic Oncology31 citations
Semantic Scholar
Clinical significance of primary debulking surgery and neoadjuvant chemotherapy-interval debulking surgery in advanced ovarian cancer.
S. Nishio, K. Ushijima
2020Japanese Journal of Clinical Oncology30 citations
Semantic Scholar
Epithelial borderline ovarian tumor: Diagnosis and treatment strategy
K. Ushijima, K. Kawano, N. Tsuda, S. Nishio +4 more
2015Obstetrics & Gynecology Science29 citations Open access
Semantic Scholar
Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device
N. Tsuda, K. Ushijima, K. Kawano, Shuji Takemoto +3 more
2014Journal of Gynecologic Oncology29 citations Open access
Semantic Scholar
Nuclear Y-box-binding protein-1 is a poor prognostic marker and related to epidermal growth factor receptor in uterine cervical cancer.
S. Nishio, K. Ushijima, Tomohiko Yamaguchi, Y. Sasajima +6 more
2014Gynecologic Oncology28 citations Open access
Semantic Scholar
Treatment and prognosis of bone metastasis from cervical cancer (KCOG‐G1202s)
H. Makino, S. Nishio, H. Tsubamoto, M. Shimada +6 more
2016The journal of obstetrics and gynaecology research27 citations
Semantic Scholar
Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancer
S. Nishio, M. Takekuma, S. Takeuchi, K. Kawano +15 more
2017Cancer Science23 citations Open access
Semantic Scholar
Identification of appropriate cone length to avoid positive cone margin in high grade cervical intraepithelial neoplasia
K. Kawano, N. Tsuda, S. Nishio, Koji Yonemoto +3 more
2016Journal of Gynecologic Oncology22 citations Open access
Semantic Scholar
Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer
K. Matsuo, J. Cripe, K. Kurnit, M. Kaneda +48 more
2019Gynecologic Oncology21 citations Open access
Semantic Scholar
Analysis of postoperative adjuvant therapy in 102 patients with gastric-type mucinous carcinoma of the uterine cervix: A multi-institutional study.
S. Nishio, K. Matsuo, H. Nasu, K. Murotani +11 more
2022European Journal of Surgical Oncology19 citations
Semantic Scholar
807O Nivolumab versus gemcitabine or pegylated liposomal doxorubicin for patients with platinum-resistant (advanced or recurrent) ovarian cancer: Open-label, randomized trial in Japan (NINJA trial)
K. Omatsu, J. Hamanishi, Noriyuki Katsumata, S. Nishio +6 more
202019 citations Open access
Semantic Scholar
Pretreatment systemic inflammatory markers predict survival in endometrial cancer: A Japanese Gynecologic Oncology Group 2043 exploratory data analysis.
S. Nishio, K. Murotani, W. Yamagami, Shiro Suzuki +7 more
2023Gynecologic Oncology18 citations
Semantic Scholar
What is an appropriate second-line regimen for recurrent endometrial cancer? Ancillary analysis of the SGSG012/GOTIC004/Intergroup study
S. Nagao, S. Nishio, S. Okada, Takeo Otsuki +13 more
2015Cancer Chemotherapy and Pharmacology18 citations
Semantic Scholar
A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082)
A. Furusawa, M. Takekuma, K. Mori, T. Usami +8 more
2021International Journal of Gynecological Cancer17 citations Open access
Semantic Scholar
Phase II study of adjuvant chemotherapy with paclitaxel and nedaplatin for uterine cervical cancer with lymph node metastasis
M. Takekuma, M. Shimokawa, S. Nishio, H. Omi +12 more
2018Cancer Science17 citations Open access
Semantic Scholar
Changes in the Clinicopathological Demographics of Vulvar Cancer in Japan: Increasing Oldest-Old, Stage Shifting, and Decreasing Cohort-Level Survival
S. Nishio, K. Matsuo, Takeo Shibata, S. Yamaguchi +11 more
2019Journal of Clinical Medicine16 citations Open access
Semantic Scholar
Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer: An open-label multicenter phase II trial (JGOG1079).
Terumi Tanigawa, N. Takeshima, Hideki Ishikawa, S. Nishio +20 more
2022Gynecologic Oncology15 citations
Semantic Scholar
A retrospective assessment of the safety and efficacy of laparoscopic radical hysterectomy in Japan during the early years following its introduction: a Japanese Gynecologic Oncology Group study (JGOG1081S)
E. Kobayashi, H. Kanao, M. Takekuma, S. Nishio +6 more
2021International Journal of Clinical Oncology15 citations
Semantic Scholar
Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study
K. Ushijima, K. Fujiyoshi, K. Kawano, N. Tsuda +3 more
2013Journal of Gynecologic Oncology15 citations Open access
Semantic Scholar
Surgical skill and oncological outcome of laparoscopic radical hysterectomy: JGOG1081s-A1, an ancillary analysis of the Japanese Gynecologic Oncology Group Study JGOG1081.
E. Kobayashi, E. Nakatani, Tomohito Tanaka, Y. Kawai +18 more
2022Gynecologic Oncology14 citations
Semantic Scholar
Race and nodal disease status are prognostic factors in patients with stage IVB cervical cancer
S. Nishio, K. Matsuo, Koji Yonemoto, M. Shimokawa +8 more
2018OncoTarget14 citations Open access
Semantic Scholar
CXCL14-CXCR4 and CXCL12-CXCR4 Axes May Play Important Roles in the Unique Invasion Process of Endometrioid Carcinoma With MELF-Pattern Myoinvasion
Sakiko Kojiro‐Sanada, Kaori Yasuda, S. Nishio, S. Ogasawara +3 more
2017International Journal of Gynecological Pathology14 citations
Semantic Scholar
Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology Group.
Akira Kikuchi, H. Yoshida, H. Tsuda, S. Nishio +19 more
2023Gynecologic Oncology13 citations
Semantic Scholar
Poor Treatment Outcomes of Locally Advanced Cervical Adenocarcinoma of Human Papilloma Virus Independent Type, Represented by Gastric Type Adenocarcinoma: A Multi-Center Retrospective Study (Sankai Gynecology Study Group)
Toshiyuki Seki, A. Kojima, S. Okame, S. Yamaguchi +11 more
2023Cancers12 citations Open access
Semantic Scholar
Platinum rechallenge treatment using gemcitabine plus carboplatin with or without bevacizumab for platinum-resistant ovarian cancer
H. Nasu, S. Nishio, Jongmyung Park, Teruyuki Yoshimitsu +6 more
2022International Journal of Clinical Oncology12 citations
Semantic Scholar
Surgical margin status and recurrence pattern in invasive vulvar Paget's disease: A Japanese Gynecologic Oncology Group study.
K. Matsuo, S. Nishio, S. Matsuzaki, H. Iwase +6 more
2020Gynecologic Oncology12 citations
Semantic Scholar
Prognostic factors from a randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and cisplatin in metastatic or recurrent cervical cancer: Japan Clinical Oncology Group (JCOG) trial: JCOG0505-S1
S. Nishio, R. Kitagawa, T. Shibata, H. Yoshikawa +3 more
2016Cancer Chemotherapy and Pharmacology12 citations
Semantic Scholar
A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311): Primary analysis.
M. Ishikawa, T. Shibata, T. Iwata, S. Nishio +10 more
2021Gynecologic Oncology11 citations Open access
Semantic Scholar
Propensity score-matched analysis of systemic chemotherapy versus salvage hysterectomy for persistent cervical cancer after definitive radiotherapy/concurrent chemoradiotherapy
M. Takekuma, Fumiaki Takahashi, S. Mabuchi, Wataru Kudaka +16 more
2020BMC Cancer11 citations Open access
Semantic Scholar
Validation of the 2021 FIGO staging schema for advanced vulvar cancer
K. Matsuo, M. Klar, S. Nishio, M. Mikami +2 more
2022International Journal of Gynecological Cancer10 citations Open access
Semantic Scholar
Investigation of clinicopathological features of vulvar cancer in 1068 patients: A Japanese Gynecologic Oncology Group (JGOG) nationwide survey study.
S. Nishio, K. Murotani, Sari Nakao, Motoki Takenaka +10 more
2020Gynecologic Oncology10 citations
Semantic Scholar
A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study)
H. Fujiwara, K. Ushijima, S. Nagao, Yuji Takei +16 more
2019International Journal of Clinical Oncology10 citations
Semantic Scholar
Analysis of the relapse patterns and risk factors of endometrial cancer following postoperative adjuvant chemotherapy in a phase III randomized clinical trial.
H. Nomura, D. Aoki, N. Susumu, M. Mizuno +9 more
2019Gynecologic Oncology10 citations
Semantic Scholar
Feasibility Study of Adjuvant Chemotherapy Using Taxane Plus Carboplatin for High-Risk Patients With Uterine Cervical Non-Squamous Cell Carcinoma After Radical Hysterectomy
Seiya Sato, M. Shimada, Tsuyoshi Ohta, T. Kojimahara +6 more
2015International Journal of Gynecologic Cancer10 citations Open access
Semantic Scholar
LBA31 Randomized phase III trial of maintenance chemotherapy with tegafur-uracil versus observation following concurrent chemoradiotherapy for locally advanced cervical cancer, GOTIC-002 LUFT trial
K. Fujiwara, S. Nishio, K. Yamamoto, H. Fujiwara +16 more
2022Annals of Oncology8 citations Open access
Semantic Scholar
Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m2 versus 40 mg/m2 in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 Trial
T. Motohashi, A. Yabuno, H. Michimae, T. Ohishi +8 more
2020Journal of Gynecologic Oncology8 citations Open access
Semantic Scholar
Subcategorization of atypical glandular cells is useful to identify lesion site
K. Kawano, Tomohiko Yamaguchi, H. Nasu, S. Nishio +1 more
2020Diagnostic Cytopathology8 citations
Semantic Scholar
Current status and molecular biology of human papillomavirus‐independent gastric‐type adenocarcinoma of the cervix
S. Nishio
2023The journal of obstetrics and gynaecology research7 citations Open access
Semantic Scholar
Adjuvant Chemotherapy for Endometrial Cancer (ACE) trial: A randomized phase II study for advanced endometrial carcinoma
T. Egawa-Takata, Y. Ueda, Kimihiko Ito, K. Hori +17 more
2022Cancer Science6 citations Open access
Semantic Scholar
Human papillomavirus genotyping predicts residual/recurrent disease after local treatment for cervical intraepithelial neoplasia better than viral DNA testing
K. Kawano, N. Tsuda, H. Nasu, Shingo Tasaki +5 more
2021The journal of obstetrics and gynaecology research5 citations
Semantic Scholar
A phase II trial of irinotecan in patients with advanced or recurrent endometrial cancer and correlation with biomarker analysis.
S. Nishio, M. Shimokawa, K. Tasaki, H. Nasu +6 more
2018Gynecologic Oncology5 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Ushijima×23
Invite
K. Ushijima — researcher profile on SciRah
M. Takekuma×11
Invite
M. Takekuma — researcher profile on SciRah
M. Mikami×10
Invite
M. Mikami — researcher profile on SciRah
K. Takehara×9
Invite
K. Takehara — researcher profile on SciRah

×8

Invite

K. Kawano — researcher profile on SciRah

Invite

N. Tsuda — researcher profile on SciRah

Y. Hirashima×7

Invite

Y. Hirashima — researcher profile on SciRah

Kimihiko Ito×7

Invite

Kimihiko Ito — researcher profile on SciRah

Invite

K. Fujiwara — researcher profile on SciRah

Invite

M. Shimada — researcher profile on SciRah

Invite

T. Enomoto — researcher profile on SciRah

Invite

H. Tokunaga — researcher profile on SciRah